Related Experiment Video
Updated: Oct 8, 2025

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Recapitulating human myogenesis ex vivo using human pluripotent stem cells.
Peggie Chien1, Haibin Xi1, April D Pyle1
1Department of Microbiology, Immunology and Molecular Genetics, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Molecular Biology Institute, University of California, Los Angeles, CA, 90095, USA.
Human pluripotent stem cells (hPSCs) model human muscle development for disease research and therapies. Derived muscle stem cells offer potential cell-based treatments for skeletal muscle wasting conditions.
Area of Science:
- Developmental Biology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Human pluripotent stem cells (hPSCs) are valuable for studying human development.
- Skeletal muscle wasting diseases represent a significant therapeutic challenge.
- Cell-based therapies hold promise for muscle regeneration.
Purpose of the Study:
- To review the recapitulation of human myogenesis using hPSCs ex vivo.
- To discuss stem cell and progenitor cell states for regenerative medicine applications.
- To explore the potential of hPSC-derived muscle cells in therapeutic strategies.
Main Methods:
- Literature review of current research on hPSC differentiation.
- Analysis of stem cell and progenitor cell characteristics.
- Evaluation of functional aspects for regenerative medicine.
Main Results:
- hPSCs can model human developmental myogenesis.
- Differentiation protocols are advancing for generating muscle stem cells.
- Considerations for cell state and function are crucial for therapeutic translation.
Conclusions:
- hPSCs offer a powerful platform for studying muscle development and disease.
- hPSC-derived muscle cells show potential for cell-based regenerative therapies.
- Further research on optimizing cell state and function is needed for clinical applications.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic to iPS Cell Reprogramming

